期刊文献+

HPV感染与宫颈癌预防的研究进展 被引量:25

Research Progress of HPV Infection and Cervical Cancer Prevention
原文传递
导出
摘要 宫颈癌在全球范围内依然是严重威胁妇女健康的常见恶性肿瘤之一。流行病学调查显示,高危型HPV持续感染是导致宫颈癌发病的主要原因,并且HPV感染具有显著的特点,因此,预防HPV感染是防治宫颈癌的主要途径。已明确性行为是促进HPV感染最重要的辅助因子,个体免疫力低下及年龄因素亦是促进HPV感染的重要因素。研究显示,在全球逐渐开展的预防措施包括对常见的高风险HPV类型进行预防性疫苗接种及包括HPV检测在内的宫颈癌筛查项目的实施已经在降低宫颈癌的发病率方面起到了很重要的作用。近些年来,人们越来越重视HPV检测在宫颈癌筛查程序中的应用。由于HPV的感染率具有显著的地域性差异,我们需要针对各地区的特点以完善相应的宫颈癌筛查程序,从而为宫颈癌防治工作的开展提供重要依据。 Cervical cancer is still one of the most serious malignant tumors in the world, which is threat to women's health and life. According to the survey of epidemiology, the persistent infection of high-risk HPV is the major cause of cervical cancer, and HPV infection has remarkable characteristics. Therefore, prevention of HPV infection is the main way to prevent and treat the cervical cancer. As we all know that sexual behavior is the most important cofactor to promote HPV infection. Individual low immunity and age are also important factors of HPV promotion. Research shows preventive measures carried out gradually around the world including prophylactic vaccination of common high-risk HPV types and the implementation of cervical cancer screening programs including HPV detection have played a very important role in reducing the incidence of cervical cancer. In recent years, people pay more and more attention to the application of the detection of HPV in cervical cancer screening programs. As HPV infection rate has significant regional differences, we need to contrapose the characteristics of the regions to improve cervical cancer screening program accordingly, so as to provide important basis for prevention and treatment of cervical cancer.
出处 《现代生物医学进展》 CAS 2014年第20期3988-3990,共3页 Progress in Modern Biomedicine
关键词 HPV 宫颈癌 感染 HPV Cervical cancer Infection
  • 相关文献

参考文献24

  • 1Denny L.Cervical cancer prevention:new opportunities for primary and secondary prevention in the 21st century [J]. Int J Gynecol Obstet, 2012, 119(Suppl 1 ): 80-84.
  • 2Alam MS, Ali A, Mehdi SJ, et al. HPV typing and its relation with apoptosis in cervical carcinoma from Indian population [J]. Tumour Biol, 2012, 33( 1 ): 17-22.
  • 3KoliopoUlos G, Valasoulis G, Zilakou E.An update review on HPV testing methods for cervical neoplasia [J]. Expert Opinion on Medical Diagnostics, 2009, 3(2): 123-13 1.
  • 4Halfon P, Benmoum D, Khiri H, et al. Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Pap- illocheck HPV-screening assay[J]. J Clin Virol, 2010, 47( 1 ): 38-42.
  • 5Ramogola-Masire D, MeG ruth CM, Barnhart KT, et al. Subtype Distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana [J]. Int J Gyneeol Pathol, 2011, 30(6): 591-596.
  • 6Kjaer SK, Breugelmans G, Munk C, et al. Population-based prevalenc- e, type- and age-specific distribution of HPVin women before introducti- on of an HPV-vaccination program in Denmark[J]. Int J Cancer, 2008, 123(8): 1864-1870.
  • 7Sanchez GI, Kleter B, Gheit T, et al. Clinical evaluation of polymerase chain reaction reverse hybridization assay for detection and identifica- tion of human papillomavirus type 16 variants [J]. J Clin Virol, 2011, 51(3): 165-169.
  • 8Abdelmutti N, Hoffman-Goetz L. Risk Messages about I-IPV, Cervical Cancer, and the HPV Vaccine Gardasil in North American News Magazines[J]. J Cancer Educ, 2010, 25(3): 451-456.
  • 9Erica R, Heitmann, Diane M, et al. Prophylactic HPV Vaccines and Prevention of Cervical Intraepithelial Neoplasia[J]. Current Obstetrics and Gynecology Reports, 2012, 1 (3): 95-105.
  • 10Esmaeili M, Bonyadi M, Dastranj A, et al. HPV typing in women with cervical precancerous and cancerous lesions in northwestern lran[J]. Gynecol Obstet Invest, 2008, 66( 1 ): 68-72.

同被引文献175

  • 1卜杰,索丽君.恶性肿瘤住院病人发病趋势分析[J].中国公共卫生管理,2013,29(6):807-808. 被引量:2
  • 2Halfon P, Benmoura D, Khiri HA, et al. Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck (R) HPV-screening assay[J]. J Clin Virol,2010,47(1) :38-42.
  • 3Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:an interim analysis of a phase Ⅲ double-blind, randomised controlledtrial[J].Lancet, 2007,369(9580) :2161-2170.
  • 4Woodman CB, Cotlins S, Winter H, et al. Natural history of cervicalhuman papillomavirus infection in young women: a longitudinalcohort study[J]. Lancet, 2001,357 (9271) : 1831-1836.
  • 5Del Mistro A,Frayle-Salamanca H, Trevisan R, et al. Tri-age of women with atypical squamous cells of undeter- mined significance (ASC-US) :Results of an Italian multi- centric study[J]. Gynecol Oncol, 2010,117(1) : 77-81.
  • 6Gyllensten U, Sanner K, Gustavsson I, et al. Short-time re- peat high-risk HPV testing by self-sampIing for screening of cervical cancer[J]. Br J Cancer, 2011,105(5) : 694-697.
  • 7Fernandes JV,Meissner RV,Carvalho MG,et al.Prevalence of human pa- pillomavirus in archival samples obtained from patients with cervical pre- malignant and malignant lesions from Northeast Brazil[J].BMC Res Notes,2010,3(1):96.
  • 8Das D,Rai AK,Kataki AC,et al.Nested multiplex PCR based detection of human papillomavirus in cervical carcinoma patients of North-East In- dia[J].Asian Pac J Cancer Prev,2013,14(2):785-790.
  • 9Munoz N,Bosch FX,de Sanjos6 S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer[J].N Engl J Med,2003,348(6):518-527.
  • 10Bosch FX,Lorincz A,Munoz N,et al.The causal relation between human papillomavirus and cervical cancer[J].J Clin Pathol,2002,55(4):244-246.

引证文献25

二级引证文献247

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部